GLP2R: Glucagon-like peptide 2 receptor
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
This is a receptor for glucagon-like peptide 2.
- Drugs that act on it: 3
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Teduglutide | Approved | Glucagon-like peptide 2 receptor agonist | Agonist | — |
| Elsiglutide | — | Glucagon-like peptide 2 receptor agonist | Agonist | — |
| FE 203799 | — | Glucagon-like peptide 2 receptor agonist | Agonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Primary short bowel syndrome
- 0.37
- Malabsorption syndrome
- 0.37
- Alcohol drinking
- 0.30
- Ovarian dysfunction
- 0.29
- Urolithiasis
- 0.24
- Humerus fracture
- 0.21
- Optic neuritis
- 0.20
- Neuropathy
- 0.20
- Type 2 diabetes mellitus
- 0.17
- Crohn disease
- 0.10
Drugs and mechanisms are from ChEMBL CHEMBL5844 (CC BY-SA 3.0). Gene name, function (UniProt O95838, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets